This inventor holds 40 USPTO granted patents and 12 published patent applications, plus 2 CIPO patents and 18 EPO patents, primarily in Oligonucleotide Delivery. Top assignees: Sirna Therapeutics, Inc., Merck Sharp + Dohme Corp., Merck + Co., Inc.. Active years: 2002-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Princetion Junction, NJ (US) (2014)
- West Point, NJ (US) (2018)
- Princeton Junction, NJ (US) (2002 - 2020)
- West Point, PA (US) (2016 - 2021)
- Princeton, NJ (US) (2018 - 2022)
Company Filing History:
18 out of 140 
12 out of 2,405 
5 out of 4,770 
Years Active: 2002-2025
Areas of Expertise:
Title: The Inventive Mind of Steven L Colletti
Introduction:
Steven L Colletti, a prolific inventor based in Princeton Junction, NJ, has made significant contributions to the field of pharmaceuticals and oligonucleotide delivery. With an impressive portfolio of 39 patents, his innovative work has had a profound impact on the treatment of various diseases, particularly Type 2 diabetes mellitus.
Latest Patents:
Among his latest patents is the groundbreaking invention of antidiabetic bicyclic compounds that act as agonists of G-protein coupled receptor 40 (GPR40). These compounds show promise in the treatment of Type 2 diabetes mellitus, obesity, and lipid disorders. Additionally, Steven Colletti has pioneered the development of tetraGalNAc and peptide-containing conjugates for the delivery of oligonucleotides, offering a novel approach to targeted drug delivery.
Career Highlights:
Throughout his career, Steven L Colletti has held key positions at renowned companies such as Sirna Therapeutics, Inc. and Merck Sharp & Dohme Corporation. His expertise and innovative spirit have been instrumental in driving advancements in the pharmaceutical industry, leading to the development of cutting-edge therapies and treatment options.
Collaborations:
Steven Colletti has collaborated with esteemed coworkers such as Matthew G Stanton and Weimin Wang, further enhancing his research capabilities and fostering a collaborative environment to push the boundaries of scientific discovery.
Conclusion:
In conclusion, Steven L Colletti stands as a luminary in the world of pharmaceutical innovation, with a remarkable track record of patents and groundbreaking inventions. His dedication to improving healthcare outcomes and advancing drug delivery technologies underscores his commitment to driving positive change in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile